Tamsulosin Hydrochloride Capsule
Product Images NDC 68071-4872

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68071-4872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 4872 9)

Pdp (68071 4872 9)
This is a description of a medication made by NuCare Pharmaceuticals, Inc. The medication is in the form of an oblong olive green opaque capsule, with "CL 23" imprinted on the cap and "0.4" on the body. The medication is Tamsulosin HCI 0.4mg and is sold in bottle packaging of 90 capsules. The lot number is 000000, and the expiration date is 00-00. The NDC numbers are 68071-4872-09 and 33342-159-15. The medication is used to treat an enlarged prostate. It is important to keep the medication out of reach of children and store it at a controlled temperature of 59-86°F. The packaging also includes a warning to call a doctor for medical advice about side effects, and that side effects may be reported to the FDA at the toll-free number 1-800-FDA-1088.*
FDA Label Image

Fig (Tamsulosin Fig 1)

Fig (Tamsulosin Fig 1)
FDA Label Image

Fig (Tamsulosin Fig 2a)

Fig (Tamsulosin Fig 2a)
FDA Label Image

Fig (Tamsulosin Fig 2b)

Fig (Tamsulosin Fig 2b)
This appears to be a table or chart showing the results of a medical treatment with two different dosages and a placebo. The treatment is referred to as "0.04mg" and "0.08mg" with the placebo listed as "A=0." The chart also indicates four groups of participants denoted by "n=657," "0b41," "0631," and "1=717." The last row of the chart appears to indicate the duration of the treatment, measured in weeks. Without additional context, it is not possible to determine what condition this treatment was for or what the data represents.*
FDA Label Image

Fig (Tamsulosin Fig 3a)

Fig (Tamsulosin Fig 3a)
FDA Label Image

Fig (Tamsulosin Fig 3b)

Fig (Tamsulosin Fig 3b)
FDA Label Image

Str (Tamsulosin Str)

Str (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.